Each year, we award several grants to dermatology residents, fellows and young faculty to fund research and clinical studies related to skin cancer. This year, the Todd Nagel Memorial Award was given to Dr. William Damsky, researcher at Yale University, for his study “Elucidating and Overcoming Mechanisms of Immunotherapy Resistance in Melanoma.”
News & Research
With the recent FDA approval of the drug nivolumab (Opdivo®, previously approved for stage IV melanoma) as a treatment for stage III melanoma, we have reached the next important phase in the immunotherapy revolution. It is a revolution that most of the world’s top experts believe will one day, very possibly within a decade, turn advanced (stages III and IV) melanoma into a chronic, or even curable, disease rather than a deadly one.
We know some of our loyal readers are medical professionals, skin cancer patients and caregivers. Many of you are as invested in skin cancer-related news and research as we are! Here’s a look back at a few 2017 headlines that got our attention.